{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T10:46:52Z","timestamp":1786704412200,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T00:00:00Z","timestamp":1734134400000},"content-version":"am","delay-in-days":317,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["#ANR-10-AIRT-03"],"award-info":[{"award-number":["#ANR-10-AIRT-03"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.cyto.2023.156474","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:22:48Z","timestamp":1702599768000},"page":"156474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Interferon-Gamma-Release assay and absolute CD8 lymphocyte count for acquired immunosuppression monitoring in critically ill patients"],"prefix":"10.1016","volume":"174","author":[{"given":"Muzhda","family":"Haem Rahimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Venet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Claire","family":"Lukaszewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Peronnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Cerrato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Rimmel\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9961-5739","authenticated-orcid":false,"given":"Guillaume","family":"Monneret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2023.156474_b0005","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nri3552","article-title":"Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2023.156474_b0010","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2017.36","article-title":"The immunopathology of sepsis and potential therapeutic targets","volume":"17","author":"van der Poll","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cyto.2023.156474_b0015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrneph.2017.165","article-title":"Advances in the understanding and treatment of sepsis-induced immunosuppression","volume":"14","author":"Venet","year":"2018","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.cyto.2023.156474_b0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1172\/JCI82224","article-title":"Sepsis-induced immune dysfunction: can immune therapies reduce mortality?","volume":"126","author":"Delano","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cyto.2023.156474_b0025","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/CCM.0000000000002074","article-title":"Sepsis Pathophysiology, Chronic Critical Illness, and Persistent Inflammation-Immunosuppression and Catabolism Syndrome","volume":"45","author":"Mira","year":"2017","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.cyto.2023.156474_b0030","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jama.2016.2691","article-title":"MARS Consortium, Incidence, Risk Factors, and Attributable Mortality of Secondary Infections in the Intensive Care Unit After Admission for Sepsis","volume":"315","author":"van Vught","year":"2016","journal-title":"JAMA."},{"key":"10.1016\/j.cyto.2023.156474_b0035","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13613-022-01051-3","article-title":"REALISM study group, A stratification strategy to predict secondary infection in critical illness-induced immune dysfunction: the REALIST score","volume":"12","author":"Tremblay","year":"2022","journal-title":"Ann. Intensive Care."},{"key":"10.1016\/j.cyto.2023.156474_b0040","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/jcm11010096","article-title":"Concomitant Assessment of Monocyte HLA-DR Expression and Ex Vivo TNF-\u03b1 Release as Markers of Adverse Outcome after Various Injuries\u2014Insights from the REALISM Study","volume":"11","author":"Bidar","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.cyto.2023.156474_b0045","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/s41577-018-0029-z","article-title":"IFN\u03b3: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy","volume":"18","author":"Ivashkiv","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"192","key":"10.1016\/j.cyto.2023.156474_b0050","first-page":"3618","article-title":"Polymicrobial sepsis alters antigen-dependent and -independent memory CD8 T cell functions","volume":"1950","author":"Duong","year":"2014","journal-title":"J. Immunol. Baltim. Md"},{"issue":"206","key":"10.1016\/j.cyto.2023.156474_b0055","first-page":"23","article-title":"A Whole Blood Enzyme-Linked Immunospot Assay for Functional Immune Endotyping of Septic Patients","volume":"1950","author":"Mazer","year":"2021","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.cyto.2023.156474_b0060","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1093\/cid\/cix1008","article-title":"Evaluation of a Novel Global Immunity Assay to Predict Infection in Organ Transplant Recipients","volume":"66","author":"Mian","year":"2018","journal-title":"Clin. Infect. Dis. off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.cyto.2023.156474_b0065","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1097\/TP.0000000000000078","article-title":"A novel biomarker of immune function and initial experience in a transplant population","volume":"97","author":"Sood","year":"2014","journal-title":"Transplantation."},{"key":"10.1016\/j.cyto.2023.156474_b0070","first-page":"1569","article-title":"Immune function biomarker QuantiFERON-monitor is associated with infection risk in cirrhotic patients, World","volume":"8","author":"Sood","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cyto.2023.156474_b0075","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/CCM.0000000000005270","article-title":"Rimmel\u00e9, for the R. study Group, Immune Profiling Demonstrates a Common Immune Signature of Delayed Acquired Immunodeficiency in Patients With Various Etiologies of Severe Injury*","volume":"50","author":"Venet","year":"2022","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.cyto.2023.156474_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156263","article-title":"Fully automated interferon-\u03b3 release assay to monitor antigen-independent T cell functionality: A proof of concept study in septic shock","volume":"169","author":"Haem Rahimi","year":"2023","journal-title":"Cytokine."},{"key":"10.1016\/j.cyto.2023.156474_b0085","doi-asserted-by":"crossref","first-page":"e015734","DOI":"10.1136\/bmjopen-2016-015734","article-title":"REALISM study group, The REAnimation Low Immune Status Markers (REALISM) project: a protocol for broad characterisation and follow-up of injury-induced immunosuppression in intensive care unit (ICU) critically ill patients","volume":"7","author":"Rol","year":"2017","journal-title":"BMJ Open."},{"key":"10.1016\/j.cyto.2023.156474_b0090","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.cca.2019.11.018","article-title":"Functional immune assay using interferon-gamma could predict infectious events in end-stage kidney disease","volume":"502","author":"Boyer-Suavet","year":"2020","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"10.1016\/j.cyto.2023.156474_b0095","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cyto.2017.09.029","article-title":"Decreased intra-lymphocyte cytokines measurement in septic shock patients: A proof of concept study in whole blood","volume":"104","author":"Letessier","year":"2018","journal-title":"Cytokine."},{"key":"10.1016\/j.cyto.2023.156474_b0100","doi-asserted-by":"crossref","unstructured":"K.E. Remy, M. Mazer, D.A. Striker, A.H. Ellebedy, A.H. Walton, J. Unsinger, T.M. Blood, P.A. Mudd, D.J. Yi, D.A. Mannion, D.F. Osborne, R.S. Martin, N.J. Anand, J.P. Bosanquet, J. Blood, A.M. Drewry, C.C. Caldwell, I.R. Turnbull, S.C. Brakenridge, L.L. Moldwawer, R.S. Hotchkiss, Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections, JCI Insight. 5 (2020) e140329, 140329. https:\/\/doi.org\/10.1172\/jci.insight.140329.","DOI":"10.1172\/jci.insight.140329"},{"key":"10.1016\/j.cyto.2023.156474_b0105","doi-asserted-by":"crossref","first-page":"e13260","DOI":"10.1111\/tid.13260","article-title":"The QuantiFERON Monitor\u00ae assay is predictive of infection post allogeneic hematopoietic cell transplantation","volume":"22","author":"Douglas","year":"2020","journal-title":"Transpl. Infect. Dis. off. J. Transplant. Soc."},{"key":"10.1016\/j.cyto.2023.156474_b0110","doi-asserted-by":"crossref","first-page":"e13550","DOI":"10.1111\/tid.13550","article-title":"Evaluation of Quantiferon\u00ae-Monitor as a biomarker of immunosuppression and predictor of infection in lung transplant recipients","volume":"23","author":"Gardiner","year":"2021","journal-title":"Transpl. Infect. Dis. off. J. Transplant. Soc."},{"key":"10.1016\/j.cyto.2023.156474_b0115","doi-asserted-by":"crossref","first-page":"e21010","DOI":"10.1097\/MD.0000000000021010","article-title":"Evaluation of cell-mediated immune response by QuantiFERON Monitor Assay in kidney transplant recipients presenting with infective complications","volume":"99","author":"Margeta","year":"2020","journal-title":"Medicine (baltimore)."},{"key":"10.1016\/j.cyto.2023.156474_b0120","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13054-023-04436-3","article-title":"Identification of a sub-group of critically ill patients with high risk of intensive care unit-acquired infections and poor clinical course using a transcriptomic score","volume":"27","author":"Bodinier","year":"2023","journal-title":"Crit. Care Lond. Engl."},{"key":"10.1016\/j.cyto.2023.156474_b0125","article-title":"Immunological Endotyping of Chronic Critical Illness After Severe Sepsis","volume":"7","author":"Fenner","year":"2020","journal-title":"Front. Med."},{"key":"10.1016\/j.cyto.2023.156474_b0130","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3390\/microorganisms11051119","article-title":"Multi-Omics Endotypes in ICU Sepsis-Induced Immunosuppression","volume":"11","author":"Garduno","year":"2023","journal-title":"Microorganisms."},{"key":"10.1016\/j.cyto.2023.156474_b0135","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13054-019-2372-2","article-title":"Heterogeneity in sepsis: new biological evidence with clinical applications","volume":"23","author":"Leligdowicz","year":"2019","journal-title":"Crit. Care Lond. Engl."},{"key":"10.1016\/j.cyto.2023.156474_b0140","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-med-043021-014005","article-title":"Biological Phenotyping in Sepsis and Acute Respiratory Distress Syndrome","volume":"74","author":"Sinha","year":"2023","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.cyto.2023.156474_b0145","first-page":"27","article-title":"Single-cell transcriptome profiling of sepsis identifies HLA-DRlowS100Ahigh monocytes with immunosuppressive function","volume":"10","author":"Yao","year":"2023","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.cyto.2023.156474_b0150","doi-asserted-by":"crossref","unstructured":"B. Francois, R. Jeannet, T. Daix, A.H. Walton, M.S. Shotwell, J. Unsinger, G. Monneret, T. Rimmel\u00e9, T. Blood, M. Morre, A. Gregoire, G.A. Mayo, J. Blood, S.K. Durum, E.R. Sherwood, R.S. Hotchkiss, Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial, JCI Insight. 3 (2018) e98960, 98960. https:\/\/doi.org\/10.1172\/jci.insight.98960.","DOI":"10.1172\/jci.insight.98960"},{"key":"10.1016\/j.cyto.2023.156474_b0155","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/CCM.0000000000003685","article-title":"Immune Checkpoint Inhibition in Sepsis: A Phase 1b Randomized, Placebo-Controlled, Single Ascending Dose Study of Antiprogrammed Cell Death-Ligand 1 Antibody (BMS-936559)","volume":"47","author":"Hotchkiss","year":"2019","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.cyto.2023.156474_b0160","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1164\/rccm.200903-0363OC","article-title":"Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial","volume":"180","author":"Meisel","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cyto.2023.156474_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.05.002","article-title":"IFN-\u03b3: A cytokine at the right time, is in the right place","volume":"43","author":"Burke","year":"2019","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.cyto.2023.156474_b0170","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1473-3099(16)30541-2","article-title":"Nivolumab plus interferon-\u03b3 in the treatment of intractable mucormycosis","volume":"17","author":"Grimaldi","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.cyto.2023.156474_b0175","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1086\/382075","article-title":"Successful treatment of a critically ill patient with disseminated coccidioidomycosis, using adjunctive interferon-gamma","volume":"38","author":"Kuberski","year":"2004","journal-title":"Clin. Infect. Dis. off. Publ. Infect. Dis. Soc. Am."},{"key":"10.1016\/j.cyto.2023.156474_b0180","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mmcr.2022.06.003","article-title":"Nivolumab and interferon-\u03b3 rescue therapy to control mixed mould and bacterial superinfection after necrotizing fasciitis and septic shock","volume":"37","author":"Lukaszewicz","year":"2022","journal-title":"Med. Mycol. Case Rep."},{"key":"10.1016\/j.cyto.2023.156474_b0185","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1186\/s12879-019-4526-x","article-title":"Multicentric experience with interferon gamma therapy in sepsis induced immunosuppression. A case series","volume":"19","author":"Payen","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.cyto.2023.156474_b0190","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.883638","article-title":"Interferon gamma as an immune modulating adjunct therapy for invasive mucormycosis after severe burn - A case report","volume":"13","author":"Tawfik","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cyto.2023.156474_b0195","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nm0697-678","article-title":"Monocyte deactivation in septic patients: Restoration by IFN-\u03b3 treatment","volume":"3","author":"D\u00f6cke","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.cyto.2023.156474_b0200","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1164\/rccm.201301-0036CP","article-title":"Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change?","volume":"187","author":"Leentjens","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cyto.2023.156474_b0205","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1097\/00003246-200207000-00015","article-title":"Immunoparalysis in patients with severe trauma and the effect of inhaled interferon-gamma","volume":"30","author":"Nakos","year":"2002","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.cyto.2023.156474_b0210","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41591-022-01843-x","article-title":"Redefining critical illness","volume":"28","author":"Maslove","year":"2022","journal-title":"Nat. Med."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466623003526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466623003526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T09:47:24Z","timestamp":1736329644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466623003526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":42,"alternative-id":["S1043466623003526"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156474","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon-Gamma-Release assay and absolute CD8 lymphocyte count for acquired immunosuppression monitoring in critically ill patients","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156474","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"156474"}}